2. UroToday Home
  3. Recent Abstracts
  4. Endourology & Urolithiasis
  5. Minimally Invasive Procedures

EAU 2018: Minimal Invasive Simple Prostatectomy: Analysis of 207 cases

Copenhagen, Denmark (UroToday.com) Benign prostatic hyperplasia (BPH) is of significant impact to patient’s quality of life, particularly in those with moderate-to-severe lower urinary tract symptoms (LUTS) for those with prostate volumes over 80 mL. While transurethral resection of the prostate (TURP) is one of the most common procedures for the treatment of BPH, minimally invasive surgical techniques have allowed the simple prostatectomy to be a significant contender, especially when considering its proven durability and long-term efficacy.

Dr. Carrion (MD) of the Hospital Universitario Nuestra Senora La Candelaria in Santa Cruz de Tenerife, Canary presents a retrospective analysis of 207 simple prostatectomy procedures performed via laparoscopy.

As a retrospective cohort analysis, the present study reads similarly to a feasibility study. Mean age and PSA was 68.93 years and 5.7 ng/mL, respectively. Mean operative time of the simple prostatectomy was 126 minutes (range 45 to 320 minutes). Post-operatively, peak flow rate improved from a baseline of 8.3 to 21.0 and all patients experienced an improvement in IPSS score (p<0.001). Of note, this cohort is similar to other centers reporting the simple prostatectomy as a feasible means to treat LUTS in BPH patients.

In contrast to the favorable outcomes and comparable patient cohort, however, was a 4.2 day average hospital stay and 7% transfusion rate. Other complications were Febril UTI in 6 patients, hematuria in 15 patients, and urinary retention in 2 patients. In response to critiques from the chairs and audience, Dr. Carrion asserted that these patients were of higher risk for post-operative complication and recurrence and, despite limitations, concludes that a laparoscopic simple prostatectomy is a good treatment alternative for LUTS in patients with BPH. Future prospective studies are recommended to confirm this benefit.

Authors: Carrión Valencia A. 1 , Samper Mateo P. 2 , Zarraonandía Andraca A. 3 , Rodríguez Nuñez H. 3 , González Dacal J.A. 3 , García-Riestra V. 3 , Ruibal Moldes M. 3

Written by: Linda M. Huynh, B.S., University of California-Irvine, at the 2018 European Association of Urology Meeting EAU18, 16-20 March, 2018 Copenhagen, Denmark